SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-16-028395
Filing Date
2016-03-25
Accepted
2016-03-25 11:06:02
Documents
94
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K dffn20151231_10k.htm 10-K 1814419
2 EXHIBIT 3.3 ex3-3.htm EX-3.3 31692
3 EXHIBIT 3.4 ex3-4.htm EX-3.4 153169
4 EXHIBIT 4.7 ex4-7.htm EX-4.7 36527
5 EXHIBIT 10.3 ex10-3.htm EX-10.3 79486
6 EXHIBIT 10.24 ex10-24.htm EX-10.24 25019
7 EXHIBIT 21.1 ex21-1.htm EX-21.1 10137
8 EXHIBIT 23.1 ex23-1.htm EX-23.1 2779
9 EXHIBIT 31.1 ex31-1.htm EX-31.1 11583
10 EXHIBIT 31.2 ex31-2.htm EX-31.2 11478
11 EXHIBIT 32.1 ex32-1.htm EX-32.1 7199
12 EXHIBIT 32.2 ex32-2.htm EX-32.2 7106
19 ex10-24img001.jpg GRAPHIC 9005
20 pancreas.jpg GRAPHIC 24313
21 adesigngraph.jpg GRAPHIC 40158
22 resx20151231_10kimg003.gif GRAPHIC 18964
23 resx20151231_10kimg002.jpg GRAPHIC 28943
24 resx20151231_10kimg001.jpg GRAPHIC 21585
  Complete submission text file 0001437749-16-028395.txt   7480992

Data Files

Seq Description Document Type Size
13 EXHIBIT 101.INS dffn-20151231.xml EX-101.INS 1108735
14 EXHIBIT 101.SCH dffn-20151231.xsd EX-101.SCH 86294
15 EXHIBIT 101.CAL dffn-20151231_cal.xml EX-101.CAL 42297
16 EXHIBIT 101.DEF dffn-20151231_def.xml EX-101.DEF 513596
17 EXHIBIT 101.LAB dffn-20151231_lab.xml EX-101.LAB 455331
18 EXHIBIT 101.PRE dffn-20151231_pre.xml EX-101.PRE 538383
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-24477 | Film No.: 161529010
SIC: 2834 Pharmaceutical Preparations